What is the size of the CAR-T Cell Therapies market in 2023?

The CAR-T Cell Therapies market size is USD 2.8 billion in 2023.

What is the projected CAGR at which the CAR-T Cell Therapies market is expected to grow at?

The CAR-T Cell Therapies market is expected to grow at a CAGR of 13.8% (2024-2033).

List the key industry players of the CAR-T Cell Therapies market?

Juno Therapeutics Inc., Bristol-Myers Squibb Company, Bluebird Bio Inc., Gilead Sciences Inc., Merck & Co. Inc., Pfizer Inc., Sorrento Therapeutics Inc., Merck KGaA, Amgen Inc., Eureka Therapeutics Inc., Calyxt Inc., Autolus Therapeutics, CARsgen Therapeutics Co.Ltd., Poseida Therapeutics Inc., Fortress Biotech Inc.

Which region is more appealing for vendors employed in the CAR-T Cell Therapies market?

North America is expected to account for the highest revenue share of 61.49% and boasting an impressive market value of USD 1.8 billion. Therefore, the CAR-T Cell Therapies industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for CAR-T Cell Therapies?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the CAR-T Cell Therapies Market.

Global CAR-T Cell Therapies Market By Drug Type (Axicabtagene Cilolecucel, Tisagenlecleucel, Brezucabtagene Autoleucel, Brexucabtagene Autoleucel, Lisocabtagene Maraleucel), By Modality (Research and Commercialized), By Target Antigen (CD19, CD22, BCMA, and Others), By Indication, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

Published date: Feb 2023
Report ID: 105628
Number of Pages: 310
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
  - 1.4. Key Analysis
  - 1.5. Key Findings by Major Segments
  - 1.6. Top strategies by Major Players
- 2. Global CAR-T Cell Therapies Market Overview
  - 2.1. CAR-T Cell Therapies Market Dynamics
    2.1.1. Drivers
    2.1.2. Opportunities
    2.1.3. Restraints
    2.1.4. Challenges
  - 2.2. Macro-economic Factors
  - 2.3. Regulatory Framework
  - 2.4. Market Investment Feasibility Index
  - 2.5. PEST Analysis
  - 2.6. PORTER’S Five Force Analysis
  - 2.7. Drivers & Restraints Impact Analysis
  - 2.8. Industry Chain Analysis
  - 2.9. Cost Structure Analysis
  - 2.10. Marketing Strategy
  - 2.11. Russia-Ukraine War Impact Analysis
  - 2.12. Opportunity Map Analysis
  - 2.13. Market Competition Scenario Analysis
  - 2.14. Product Life Cycle Analysis
  - 2.15. Opportunity Orbits
  - 2.16. Manufacturer Intensity Map
  - 2.17. Major Companies sales by Value & Volume
- 3. Global CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, 2016-2032
  - 3.1. Global CAR-T Cell Therapies Market Analysis, 2016-2021
  - 3.2. Global CAR-T Cell Therapies Market Opportunity and Forecast, 2023-2032
  - 3.3. Global CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    3.3.1. Global CAR-T Cell Therapies Market Analysis by Drug Type: Introduction
    3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    3.3.3. Axicabtagene Ciloleucel
    3.3.4. Tisagenlecleucel
    3.3.5. Brexucabtagene Autoleucel
    3.3.6. Lisocabtagene maraleucel
    3.3.7. Other Drug Types
  - 3.4. Global CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Modality, 2016-2032
    3.4.1. Global CAR-T Cell Therapies Market Analysis by Modality: Introduction
    3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Modality, 2016-2032
    3.4.3. Research
    3.4.4. Commercialized
  - 3.5. Global CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Target Antigen, 2016-2032
    3.5.1. Global CAR-T Cell Therapies Market Analysis by Target Antigen: Introduction
    3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Target Antigen, 2016-2032
    3.5.3. CD19
    3.5.4. CD22
    3.5.5. BCMA
    3.5.6. Other Target Antigens
  - 3.6. Global CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Indication, 2016-2032
    3.6.1. Global CAR-T Cell Therapies Market Analysis by Indication: Introduction
    3.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Indication, 2016-2032
    3.6.3. Lymphoma
    3.6.4. Acute Lymphocytic Leukemia
    3.6.5. Autoimmune Disorders
    3.6.6. Other Indications
  - 3.7. Global CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    3.7.1. Global CAR-T Cell Therapies Market Analysis by End-User: Introduction
    3.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    3.7.3. Hospitals
    3.7.4. Cancer Treatment Centers
- 4. North America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, 2016-2032
  - 4.1. North America CAR-T Cell Therapies Market Analysis, 2016-2021
  - 4.2. North America CAR-T Cell Therapies Market Opportunity and Forecast, 2023-2032
  - 4.3. North America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    4.3.1. North America CAR-T Cell Therapies Market Analysis by Drug Type: Introduction
    4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    4.3.3. Axicabtagene Ciloleucel
    4.3.4. Tisagenlecleucel
    4.3.5. Brexucabtagene Autoleucel
    4.3.6. Lisocabtagene maraleucel
    4.3.7. Other Drug Types
  - 4.4. North America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Modality, 2016-2032
    4.4.1. North America CAR-T Cell Therapies Market Analysis by Modality: Introduction
    4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Modality, 2016-2032
    4.4.3. Research
    4.4.4. Commercialized
  - 4.5. North America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Target Antigen, 2016-2032
    4.5.1. North America CAR-T Cell Therapies Market Analysis by Target Antigen: Introduction
    4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Target Antigen, 2016-2032
    4.5.3. CD19
    4.5.4. CD22
    4.5.5. BCMA
    4.5.6. Other Target Antigens
  - 4.6. North America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Indication, 2016-2032
    4.6.1. North America CAR-T Cell Therapies Market Analysis by Indication: Introduction
    4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Indication, 2016-2032
    4.6.3. Lymphoma
    4.6.4. Acute Lymphocytic Leukemia
    4.6.5. Autoimmune Disorders
    4.6.6. Other Indications
  - 4.7. North America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    4.7.1. North America CAR-T Cell Therapies Market Analysis by End-User: Introduction
    4.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    4.7.3. Hospitals
    4.7.4. Cancer Treatment Centers
  - 4.8. North America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    4.8.1. North America CAR-T Cell Therapies Market Analysis by Country : Introduction
    4.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    4.8.2.1. The US
    4.8.2.2. Canada
    4.8.2.3. Mexico
- 5. Western Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, 2016-2032
  - 5.1. Western Europe CAR-T Cell Therapies Market Analysis, 2016-2021
  - 5.2. Western Europe CAR-T Cell Therapies Market Opportunity and Forecast, 2023-2032
  - 5.3. Western Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    5.3.1. Western Europe CAR-T Cell Therapies Market Analysis by Drug Type: Introduction
    5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    5.3.3. Axicabtagene Ciloleucel
    5.3.4. Tisagenlecleucel
    5.3.5. Brexucabtagene Autoleucel
    5.3.6. Lisocabtagene maraleucel
    5.3.7. Other Drug Types
  - 5.4. Western Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Modality, 2016-2032
    5.4.1. Western Europe CAR-T Cell Therapies Market Analysis by Modality: Introduction
    5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Modality, 2016-2032
    5.4.3. Research
    5.4.4. Commercialized
  - 5.5. Western Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Target Antigen, 2016-2032
    5.5.1. Western Europe CAR-T Cell Therapies Market Analysis by Target Antigen: Introduction
    5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Target Antigen, 2016-2032
    5.5.3. CD19
    5.5.4. CD22
    5.5.5. BCMA
    5.5.6. Other Target Antigens
  - 5.6. Western Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Indication, 2016-2032
    5.6.1. Western Europe CAR-T Cell Therapies Market Analysis by Indication: Introduction
    5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Indication, 2016-2032
    5.6.3. Lymphoma
    5.6.4. Acute Lymphocytic Leukemia
    5.6.5. Autoimmune Disorders
    5.6.6. Other Indications
  - 5.7. Western Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    5.7.1. Western Europe CAR-T Cell Therapies Market Analysis by End-User: Introduction
    5.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    5.7.3. Hospitals
    5.7.4. Cancer Treatment Centers
  - 5.8. Western Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    5.8.1. Western Europe CAR-T Cell Therapies Market Analysis by Country : Introduction
    5.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    5.8.2.1. Germany
    5.8.2.2. France
    5.8.2.3. The UK
    5.8.2.4. Spain
    5.8.2.5. Italy
    5.8.2.6. Portugal
    5.8.2.7. Ireland
    5.8.2.8. Austria
    5.8.2.9. Switzerland
    5.8.2.10. Benelux
    5.8.2.11. Nordic
    5.8.2.12. Rest of Western Europe
- 6. Eastern Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, 2016-2032
  - 6.1. Eastern Europe CAR-T Cell Therapies Market Analysis, 2016-2021
  - 6.2. Eastern Europe CAR-T Cell Therapies Market Opportunity and Forecast, 2023-2032
  - 6.3. Eastern Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    6.3.1. Eastern Europe CAR-T Cell Therapies Market Analysis by Drug Type: Introduction
    6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    6.3.3. Axicabtagene Ciloleucel
    6.3.4. Tisagenlecleucel
    6.3.5. Brexucabtagene Autoleucel
    6.3.6. Lisocabtagene maraleucel
    6.3.7. Other Drug Types
  - 6.4. Eastern Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Modality, 2016-2032
    6.4.1. Eastern Europe CAR-T Cell Therapies Market Analysis by Modality: Introduction
    6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Modality, 2016-2032
    6.4.3. Research
    6.4.4. Commercialized
  - 6.5. Eastern Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Target Antigen, 2016-2032
    6.5.1. Eastern Europe CAR-T Cell Therapies Market Analysis by Target Antigen: Introduction
    6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Target Antigen, 2016-2032
    6.5.3. CD19
    6.5.4. CD22
    6.5.5. BCMA
    6.5.6. Other Target Antigens
  - 6.6. Eastern Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Indication, 2016-2032
    6.6.1. Eastern Europe CAR-T Cell Therapies Market Analysis by Indication: Introduction
    6.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Indication, 2016-2032
    6.6.3. Lymphoma
    6.6.4. Acute Lymphocytic Leukemia
    6.6.5. Autoimmune Disorders
    6.6.6. Other Indications
  - 6.7. Eastern Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    6.7.1. Eastern Europe CAR-T Cell Therapies Market Analysis by End-User: Introduction
    6.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    6.7.3. Hospitals
    6.7.4. Cancer Treatment Centers
  - 6.8. Eastern Europe CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    6.8.1. Eastern Europe CAR-T Cell Therapies Market Analysis by Country : Introduction
    6.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    6.8.2.1. Russia
    6.8.2.2. Poland
    6.8.2.3. The Czech Republic
    6.8.2.4. Greece
    6.8.2.5. Rest of Eastern Europe
- 7. APAC CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, 2016-2032
  - 7.1. APAC CAR-T Cell Therapies Market Analysis, 2016-2021
  - 7.2. APAC CAR-T Cell Therapies Market Opportunity and Forecast, 2023-2032
  - 7.3. APAC CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    7.3.1. APAC CAR-T Cell Therapies Market Analysis by Drug Type: Introduction
    7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    7.3.3. Axicabtagene Ciloleucel
    7.3.4. Tisagenlecleucel
    7.3.5. Brexucabtagene Autoleucel
    7.3.6. Lisocabtagene maraleucel
    7.3.7. Other Drug Types
  - 7.4. APAC CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Modality, 2016-2032
    7.4.1. APAC CAR-T Cell Therapies Market Analysis by Modality: Introduction
    7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Modality, 2016-2032
    7.4.3. Research
    7.4.4. Commercialized
  - 7.5. APAC CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Target Antigen, 2016-2032
    7.5.1. APAC CAR-T Cell Therapies Market Analysis by Target Antigen: Introduction
    7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Target Antigen, 2016-2032
    7.5.3. CD19
    7.5.4. CD22
    7.5.5. BCMA
    7.5.6. Other Target Antigens
  - 7.6. APAC CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Indication, 2016-2032
    7.6.1. APAC CAR-T Cell Therapies Market Analysis by Indication: Introduction
    7.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Indication, 2016-2032
    7.6.3. Lymphoma
    7.6.4. Acute Lymphocytic Leukemia
    7.6.5. Autoimmune Disorders
    7.6.6. Other Indications
  - 7.7. APAC CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    7.7.1. APAC CAR-T Cell Therapies Market Analysis by End-User: Introduction
    7.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    7.7.3. Hospitals
    7.7.4. Cancer Treatment Centers
  - 7.8. APAC CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    7.8.1. APAC CAR-T Cell Therapies Market Analysis by Country : Introduction
    7.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    7.8.2.1. China
    7.8.2.2. Japan
    7.8.2.3. South Korea
    7.8.2.4. India
    7.8.2.5. Australia & New Zeland
    7.8.2.6. Indonesia
    7.8.2.7. Malaysia
    7.8.2.8. Philippines
    7.8.2.9. Singapore
    7.8.2.10. Thailand
    7.8.2.11. Vietnam
    7.8.2.12. Rest of APAC
- 8. Latin America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, 2016-2032
  - 8.1. Latin America CAR-T Cell Therapies Market Analysis, 2016-2021
  - 8.2. Latin America CAR-T Cell Therapies Market Opportunity and Forecast, 2023-2032
  - 8.3. Latin America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    8.3.1. Latin America CAR-T Cell Therapies Market Analysis by Drug Type: Introduction
    8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    8.3.3. Axicabtagene Ciloleucel
    8.3.4. Tisagenlecleucel
    8.3.5. Brexucabtagene Autoleucel
    8.3.6. Lisocabtagene maraleucel
    8.3.7. Other Drug Types
  - 8.4. Latin America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Modality, 2016-2032
    8.4.1. Latin America CAR-T Cell Therapies Market Analysis by Modality: Introduction
    8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Modality, 2016-2032
    8.4.3. Research
    8.4.4. Commercialized
  - 8.5. Latin America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Target Antigen, 2016-2032
    8.5.1. Latin America CAR-T Cell Therapies Market Analysis by Target Antigen: Introduction
    8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Target Antigen, 2016-2032
    8.5.3. CD19
    8.5.4. CD22
    8.5.5. BCMA
    8.5.6. Other Target Antigens
  - 8.6. Latin America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Indication, 2016-2032
    8.6.1. Latin America CAR-T Cell Therapies Market Analysis by Indication: Introduction
    8.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Indication, 2016-2032
    8.6.3. Lymphoma
    8.6.4. Acute Lymphocytic Leukemia
    8.6.5. Autoimmune Disorders
    8.6.6. Other Indications
  - 8.7. Latin America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    8.7.1. Latin America CAR-T Cell Therapies Market Analysis by End-User: Introduction
    8.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    8.7.3. Hospitals
    8.7.4. Cancer Treatment Centers
  - 8.8. Latin America CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    8.8.1. Latin America CAR-T Cell Therapies Market Analysis by Country : Introduction
    8.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    8.8.2.1. Brazil
    8.8.2.2. Colombia
    8.8.2.3. Chile
    8.8.2.4. Argentina
    8.8.2.5. Costa Rica
    8.8.2.6. Rest of Latin America
- 9. Middle East & Africa CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, 2016-2032
  - 9.1. Middle East & Africa CAR-T Cell Therapies Market Analysis, 2016-2021
  - 9.2. Middle East & Africa CAR-T Cell Therapies Market Opportunity and Forecast, 2023-2032
  - 9.3. Middle East & Africa CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    9.3.1. Middle East & Africa CAR-T Cell Therapies Market Analysis by Drug Type: Introduction
    9.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    9.3.3. Axicabtagene Ciloleucel
    9.3.4. Tisagenlecleucel
    9.3.5. Brexucabtagene Autoleucel
    9.3.6. Lisocabtagene maraleucel
    9.3.7. Other Drug Types
  - 9.4. Middle East & Africa CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Modality, 2016-2032
    9.4.1. Middle East & Africa CAR-T Cell Therapies Market Analysis by Modality: Introduction
    9.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Modality, 2016-2032
    9.4.3. Research
    9.4.4. Commercialized
  - 9.5. Middle East & Africa CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Target Antigen, 2016-2032
    9.5.1. Middle East & Africa CAR-T Cell Therapies Market Analysis by Target Antigen: Introduction
    9.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Target Antigen, 2016-2032
    9.5.3. CD19
    9.5.4. CD22
    9.5.5. BCMA
    9.5.6. Other Target Antigens
  - 9.6. Middle East & Africa CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Indication, 2016-2032
    9.6.1. Middle East & Africa CAR-T Cell Therapies Market Analysis by Indication: Introduction
    9.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Indication, 2016-2032
    9.6.3. Lymphoma
    9.6.4. Acute Lymphocytic Leukemia
    9.6.5. Autoimmune Disorders
    9.6.6. Other Indications
  - 9.7. Middle East & Africa CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    9.7.1. Middle East & Africa CAR-T Cell Therapies Market Analysis by End-User: Introduction
    9.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    9.7.3. Hospitals
    9.7.4. Cancer Treatment Centers
  - 9.8. Middle East & Africa CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    9.8.1. Middle East & Africa CAR-T Cell Therapies Market Analysis by Country : Introduction
    9.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    9.8.2.1. Algeria
    9.8.2.2. Egypt
    9.8.2.3. Israel
    9.8.2.4. Kuwait
    9.8.2.5. Nigeria
    9.8.2.6. Saudi Arabia
    9.8.2.7. South Africa
    9.8.2.8. Turkey
    9.8.2.9. The UAE
    9.8.2.10. Rest of MEA
- 10. Global CAR-T Cell Therapies Market Analysis, Opportunity and Forecast, By Region , 2016-2032
  - 10.1. Global CAR-T Cell Therapies Market Analysis by Region : Introduction
  - 10.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
    10.2.1. North America
    10.2.2. Western Europe
    10.2.3. Eastern Europe
    10.2.4. APAC
    10.2.5. Latin America
    10.2.6. Middle East & Africa
- 11. Global CAR-T Cell Therapies Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 11.1. Market Share Analysis
  - 11.2. Company Profiles
  - 11.3. Juno Therapeutics, Inc.
    11.3.1. Company Overview
    11.3.2. Financial Highlights
    11.3.3. Product Portfolio
    11.3.4. SWOT Analysis
    11.3.5. Key Strategies and Developments
  - 11.4. Bristol-Myers Squibb Company
    11.4.1. Company Overview
    11.4.2. Financial Highlights
    11.4.3. Product Portfolio
    11.4.4. SWOT Analysis
    11.4.5. Key Strategies and Developments
  - 11.5. Bluebird Bio, Inc.
    11.5.1. Company Overview
    11.5.2. Financial Highlights
    11.5.3. Product Portfolio
    11.5.4. SWOT Analysis
    11.5.5. Key Strategies and Developments
  - 11.6. Gilead Sciences, Inc.
    11.6.1. Company Overview
    11.6.2. Financial Highlights
    11.6.3. Product Portfolio
    11.6.4. SWOT Analysis
    11.6.5. Key Strategies and Developments
  - 11.7. Merck & Co., Inc.
    11.7.1. Company Overview
    11.7.2. Financial Highlights
    11.7.3. Product Portfolio
    11.7.4. SWOT Analysis
    11.7.5. Key Strategies and Developments
  - 11.8. Adeor Medical AG
    11.8.1. Company Overview
    11.8.2. Financial Highlights
    11.8.3. Product Portfolio
    11.8.4. SWOT Analysis
    11.8.5. Key Strategies and Developments
  - 11.9. Sorrento Therapeutics, Inc.
    11.9.1. Company Overview
    11.9.2. Financial Highlights
    11.9.3. Product Portfolio
    11.9.4. SWOT Analysis
    11.9.5. Key Strategies and Developments
  - 11.10. Merck KGaA
    11.10.1. Company Overview
    11.10.2. Financial Highlights
    11.10.3. Product Portfolio
    11.10.4. SWOT Analysis
    11.10.5. Key Strategies and Developments
  - 11.11. Amgen Inc.
    11.11.1. Company Overview
    11.11.2. Financial Highlights
    11.11.3. Product Portfolio
    11.11.4. SWOT Analysis
    11.11.5. Key Strategies and Developments
  - 11.12. Eureka Therapeutics Inc.
    11.12.1. Company Overview
    11.12.2. Financial Highlights
    11.12.3. Product Portfolio
    11.12.4. SWOT Analysis
    11.12.5. Key Strategies and Developments
  - 11.13. Calyxt Inc.
    11.13.1. Company Overview
    11.13.2. Financial Highlights
    11.13.3. Product Portfolio
    11.13.4. SWOT Analysis
    11.13.5. Key Strategies and Developments
  - 11.14. Autolus Therapeutics
    11.14.1. Company Overview
    11.14.2. Financial Highlights
    11.14.3. Product Portfolio
    11.14.4. SWOT Analysis
    11.14.5. Key Strategies and Developments
  - 11.15. CARsgen Therapeutics Co.Ltd.
    11.15.1. Company Overview
    11.15.2. Financial Highlights
    11.15.3. Product Portfolio
    11.15.4. SWOT Analysis
    11.15.5. Key Strategies and Developments
  - 11.16. Poseida Therapeutics, Inc.
    11.16.1. Company Overview
    11.16.2. Financial Highlights
    11.16.3. Product Portfolio
    11.16.4. SWOT Analysis
    11.16.5. Key Strategies and Developments
  - 11.17. Fortress Biotech, Inc
    11.17.1. Company Overview
    11.17.2. Financial Highlights
    11.17.3. Product Portfolio
    11.17.4. SWOT Analysis
    11.17.5. Key Strategies and Developments
  - 11.18. Other Key Players
    11.18.1. Company Overview
    11.18.2. Financial Highlights
    11.18.3. Product Portfolio
    11.18.4. SWOT Analysis
    11.18.5. Key Strategies and Developments
- 12. Assumptions and Acronyms
- 13. Research Methodology
- 14. Contact
- List of Figures
  - Figure 1: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Drug Type in 2022
  - Figure 2: Global CAR-T Cell Therapies Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 3: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Modalityin 2022
  - Figure 4: Global CAR-T Cell Therapies Market Attractiveness Analysis by Modality, 2016-2032
  - Figure 5: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Target Antigenin 2022
  - Figure 6: Global CAR-T Cell Therapies Market Attractiveness Analysis by Target Antigen, 2016-2032
  - Figure 7: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Indicationin 2022
  - Figure 8: Global CAR-T Cell Therapies Market Attractiveness Analysis by Indication, 2016-2032
  - Figure 9: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by End-Userin 2022
  - Figure 10: Global CAR-T Cell Therapies Market Attractiveness Analysis by End-User, 2016-2032
  - Figure 11: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Region in 2022
  - Figure 12: Global CAR-T Cell Therapies Market Attractiveness Analysis by Region, 2016-2032
  - Figure 13: Global CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Figure 14: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Figure 15: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 16: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Figure 17: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Figure 18: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Figure 19: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Figure 20: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
  - Figure 21: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 22: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Figure 23: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Figure 24: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Figure 25: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Figure 26: Global CAR-T Cell Therapies Market Share Comparison by Region (2016-2032)
  - Figure 27: Global CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Figure 28: Global CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Figure 29: Global CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Figure 30: Global CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Figure 31: Global CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Figure 32: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 33: North America CAR-T Cell Therapies Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 34: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Modalityin 2022
  - Figure 35: North America CAR-T Cell Therapies Market Attractiveness Analysis by Modality, 2016-2032
  - Figure 36: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Target Antigenin 2022
  - Figure 37: North America CAR-T Cell Therapies Market Attractiveness Analysis by Target Antigen, 2016-2032
  - Figure 38: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Indicationin 2022
  - Figure 39: North America CAR-T Cell Therapies Market Attractiveness Analysis by Indication, 2016-2032
  - Figure 40: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by End-Userin 2022
  - Figure 41: North America CAR-T Cell Therapies Market Attractiveness Analysis by End-User, 2016-2032
  - Figure 42: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 43: North America CAR-T Cell Therapies Market Attractiveness Analysis by Country, 2016-2032
  - Figure 44: North America CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Figure 45: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 46: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 47: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Figure 48: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Figure 49: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Figure 50: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Figure 51: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 52: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 53: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Figure 54: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Figure 55: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Figure 56: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Figure 57: North America CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Figure 58: North America CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Figure 59: North America CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Figure 60: North America CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Figure 61: North America CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Figure 62: North America CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Figure 63: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 64: Western Europe CAR-T Cell Therapies Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 65: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Modalityin 2022
  - Figure 66: Western Europe CAR-T Cell Therapies Market Attractiveness Analysis by Modality, 2016-2032
  - Figure 67: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Target Antigenin 2022
  - Figure 68: Western Europe CAR-T Cell Therapies Market Attractiveness Analysis by Target Antigen, 2016-2032
  - Figure 69: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Indicationin 2022
  - Figure 70: Western Europe CAR-T Cell Therapies Market Attractiveness Analysis by Indication, 2016-2032
  - Figure 71: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by End-Userin 2022
  - Figure 72: Western Europe CAR-T Cell Therapies Market Attractiveness Analysis by End-User, 2016-2032
  - Figure 73: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 74: Western Europe CAR-T Cell Therapies Market Attractiveness Analysis by Country, 2016-2032
  - Figure 75: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Figure 76: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 77: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 78: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Figure 79: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Figure 80: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Figure 81: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Figure 82: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 83: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 84: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Figure 85: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Figure 86: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Figure 87: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Figure 88: Western Europe CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Figure 89: Western Europe CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Figure 90: Western Europe CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Figure 91: Western Europe CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Figure 92: Western Europe CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Figure 93: Western Europe CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Figure 94: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 95: Eastern Europe CAR-T Cell Therapies Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 96: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Modalityin 2022
  - Figure 97: Eastern Europe CAR-T Cell Therapies Market Attractiveness Analysis by Modality, 2016-2032
  - Figure 98: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Target Antigenin 2022
  - Figure 99: Eastern Europe CAR-T Cell Therapies Market Attractiveness Analysis by Target Antigen, 2016-2032
  - Figure 100: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Indicationin 2022
  - Figure 101: Eastern Europe CAR-T Cell Therapies Market Attractiveness Analysis by Indication, 2016-2032
  - Figure 102: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by End-Userin 2022
  - Figure 103: Eastern Europe CAR-T Cell Therapies Market Attractiveness Analysis by End-User, 2016-2032
  - Figure 104: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 105: Eastern Europe CAR-T Cell Therapies Market Attractiveness Analysis by Country, 2016-2032
  - Figure 106: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Figure 107: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 108: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 109: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Figure 110: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Figure 111: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Figure 112: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Figure 113: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 114: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 115: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Figure 116: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Figure 117: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Figure 118: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Figure 119: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Figure 120: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Figure 121: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Figure 122: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Figure 123: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Figure 124: Eastern Europe CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Figure 125: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 126: APAC CAR-T Cell Therapies Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 127: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Modalityin 2022
  - Figure 128: APAC CAR-T Cell Therapies Market Attractiveness Analysis by Modality, 2016-2032
  - Figure 129: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Target Antigenin 2022
  - Figure 130: APAC CAR-T Cell Therapies Market Attractiveness Analysis by Target Antigen, 2016-2032
  - Figure 131: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Indicationin 2022
  - Figure 132: APAC CAR-T Cell Therapies Market Attractiveness Analysis by Indication, 2016-2032
  - Figure 133: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by End-Userin 2022
  - Figure 134: APAC CAR-T Cell Therapies Market Attractiveness Analysis by End-User, 2016-2032
  - Figure 135: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 136: APAC CAR-T Cell Therapies Market Attractiveness Analysis by Country, 2016-2032
  - Figure 137: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Figure 138: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 139: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 140: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Figure 141: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Figure 142: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Figure 143: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Figure 144: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 145: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 146: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Figure 147: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Figure 148: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Figure 149: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Figure 150: APAC CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Figure 151: APAC CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Figure 152: APAC CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Figure 153: APAC CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Figure 154: APAC CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Figure 155: APAC CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Figure 156: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 157: Latin America CAR-T Cell Therapies Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 158: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Modalityin 2022
  - Figure 159: Latin America CAR-T Cell Therapies Market Attractiveness Analysis by Modality, 2016-2032
  - Figure 160: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Target Antigenin 2022
  - Figure 161: Latin America CAR-T Cell Therapies Market Attractiveness Analysis by Target Antigen, 2016-2032
  - Figure 162: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Indicationin 2022
  - Figure 163: Latin America CAR-T Cell Therapies Market Attractiveness Analysis by Indication, 2016-2032
  - Figure 164: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by End-Userin 2022
  - Figure 165: Latin America CAR-T Cell Therapies Market Attractiveness Analysis by End-User, 2016-2032
  - Figure 166: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 167: Latin America CAR-T Cell Therapies Market Attractiveness Analysis by Country, 2016-2032
  - Figure 168: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Figure 169: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 170: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 171: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Figure 172: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Figure 173: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Figure 174: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Figure 175: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 176: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 177: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Figure 178: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Figure 179: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Figure 180: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Figure 181: Latin America CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Figure 182: Latin America CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Figure 183: Latin America CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Figure 184: Latin America CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Figure 185: Latin America CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Figure 186: Latin America CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Figure 187: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 188: Middle East & Africa CAR-T Cell Therapies Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 189: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Modalityin 2022
  - Figure 190: Middle East & Africa CAR-T Cell Therapies Market Attractiveness Analysis by Modality, 2016-2032
  - Figure 191: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Target Antigenin 2022
  - Figure 192: Middle East & Africa CAR-T Cell Therapies Market Attractiveness Analysis by Target Antigen, 2016-2032
  - Figure 193: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Indicationin 2022
  - Figure 194: Middle East & Africa CAR-T Cell Therapies Market Attractiveness Analysis by Indication, 2016-2032
  - Figure 195: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by End-Userin 2022
  - Figure 196: Middle East & Africa CAR-T Cell Therapies Market Attractiveness Analysis by End-User, 2016-2032
  - Figure 197: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 198: Middle East & Africa CAR-T Cell Therapies Market Attractiveness Analysis by Country, 2016-2032
  - Figure 199: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Figure 200: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 201: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 202: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Figure 203: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Figure 204: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Figure 205: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Figure 206: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 207: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 208: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Figure 209: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Figure 210: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Figure 211: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Figure 212: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Figure 213: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Figure 214: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Figure 215: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Figure 216: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Figure 217: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
- List of Tables
  - Table 1: Global CAR-T Cell Therapies Market Comparison by Drug Type (2016-2032)
  - Table 2: Global CAR-T Cell Therapies Market Comparison by Modality (2016-2032)
  - Table 3: Global CAR-T Cell Therapies Market Comparison by Target Antigen (2016-2032)
  - Table 4: Global CAR-T Cell Therapies Market Comparison by Indication (2016-2032)
  - Table 5: Global CAR-T Cell Therapies Market Comparison by End-User (2016-2032)
  - Table 6: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Table 7: Global CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Table 8: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Table 9: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 10: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Table 11: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Table 12: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Table 13: Global CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Table 14: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
  - Table 15: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 16: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Table 17: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Table 18: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Table 19: Global CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Table 20: Global CAR-T Cell Therapies Market Share Comparison by Region (2016-2032)
  - Table 21: Global CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Table 22: Global CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Table 23: Global CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Table 24: Global CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Table 25: Global CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Table 26: North America CAR-T Cell Therapies Market Comparison by Modality (2016-2032)
  - Table 27: North America CAR-T Cell Therapies Market Comparison by Target Antigen (2016-2032)
  - Table 28: North America CAR-T Cell Therapies Market Comparison by Indication (2016-2032)
  - Table 29: North America CAR-T Cell Therapies Market Comparison by End-User (2016-2032)
  - Table 30: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 31: North America CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Table 32: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 33: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 34: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Table 35: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Table 36: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Table 37: North America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Table 38: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 39: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 40: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Table 41: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Table 42: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Table 43: North America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Table 44: North America CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Table 45: North America CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Table 46: North America CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Table 47: North America CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Table 48: North America CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Table 49: North America CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Table 50: Western Europe CAR-T Cell Therapies Market Comparison by Drug Type (2016-2032)
  - Table 51: Western Europe CAR-T Cell Therapies Market Comparison by Modality (2016-2032)
  - Table 52: Western Europe CAR-T Cell Therapies Market Comparison by Target Antigen (2016-2032)
  - Table 53: Western Europe CAR-T Cell Therapies Market Comparison by Indication (2016-2032)
  - Table 54: Western Europe CAR-T Cell Therapies Market Comparison by End-User (2016-2032)
  - Table 55: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 56: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Table 57: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 58: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 59: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Table 60: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Table 61: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Table 62: Western Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Table 63: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 64: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 65: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Table 66: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Table 67: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Table 68: Western Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Table 69: Western Europe CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Table 70: Western Europe CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Table 71: Western Europe CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Table 72: Western Europe CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Table 73: Western Europe CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Table 74: Western Europe CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Table 75: Eastern Europe CAR-T Cell Therapies Market Comparison by Drug Type (2016-2032)
  - Table 76: Eastern Europe CAR-T Cell Therapies Market Comparison by Modality (2016-2032)
  - Table 77: Eastern Europe CAR-T Cell Therapies Market Comparison by Target Antigen (2016-2032)
  - Table 78: Eastern Europe CAR-T Cell Therapies Market Comparison by Indication (2016-2032)
  - Table 79: Eastern Europe CAR-T Cell Therapies Market Comparison by End-User (2016-2032)
  - Table 80: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 81: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Table 82: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 83: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 84: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Table 85: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Table 86: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Table 87: Eastern Europe CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Table 88: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 89: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 90: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Table 91: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Table 92: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Table 93: Eastern Europe CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Table 94: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Table 95: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Table 96: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Table 97: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Table 98: Eastern Europe CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Table 99: Eastern Europe CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Table 100: APAC CAR-T Cell Therapies Market Comparison by Drug Type (2016-2032)
  - Table 101: APAC CAR-T Cell Therapies Market Comparison by Modality (2016-2032)
  - Table 102: APAC CAR-T Cell Therapies Market Comparison by Target Antigen (2016-2032)
  - Table 103: APAC CAR-T Cell Therapies Market Comparison by Indication (2016-2032)
  - Table 104: APAC CAR-T Cell Therapies Market Comparison by End-User (2016-2032)
  - Table 105: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 106: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Table 107: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 108: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 109: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Table 110: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Table 111: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Table 112: APAC CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Table 113: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 114: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 115: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Table 116: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Table 117: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Table 118: APAC CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Table 119: APAC CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Table 120: APAC CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Table 121: APAC CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Table 122: APAC CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Table 123: APAC CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Table 124: APAC CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Table 125: Latin America CAR-T Cell Therapies Market Comparison by Drug Type (2016-2032)
  - Table 126: Latin America CAR-T Cell Therapies Market Comparison by Modality (2016-2032)
  - Table 127: Latin America CAR-T Cell Therapies Market Comparison by Target Antigen (2016-2032)
  - Table 128: Latin America CAR-T Cell Therapies Market Comparison by Indication (2016-2032)
  - Table 129: Latin America CAR-T Cell Therapies Market Comparison by End-User (2016-2032)
  - Table 130: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 131: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Table 132: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 133: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 134: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Table 135: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Table 136: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Table 137: Latin America CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Table 138: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 139: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 140: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Table 141: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Table 142: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Table 143: Latin America CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Table 144: Latin America CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Table 145: Latin America CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Table 146: Latin America CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Table 147: Latin America CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Table 148: Latin America CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Table 149: Latin America CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
  - Table 150: Middle East & Africa CAR-T Cell Therapies Market Comparison by Drug Type (2016-2032)
  - Table 151: Middle East & Africa CAR-T Cell Therapies Market Comparison by Modality (2016-2032)
  - Table 152: Middle East & Africa CAR-T Cell Therapies Market Comparison by Target Antigen (2016-2032)
  - Table 153: Middle East & Africa CAR-T Cell Therapies Market Comparison by Indication (2016-2032)
  - Table 154: Middle East & Africa CAR-T Cell Therapies Market Comparison by End-User (2016-2032)
  - Table 155: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 156: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) (2016-2032)
  - Table 157: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 158: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 159: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Modality (2016-2032)
  - Table 160: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Target Antigen (2016-2032)
  - Table 161: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by Indication (2016-2032)
  - Table 162: Middle East & Africa CAR-T Cell Therapies Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
  - Table 163: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 164: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 165: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Modality (2016-2032)
  - Table 166: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Target Antigen (2016-2032)
  - Table 167: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by Indication (2016-2032)
  - Table 168: Middle East & Africa CAR-T Cell Therapies Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
  - Table 169: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Country (2016-2032)
  - Table 170: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Drug Type (2016-2032)
  - Table 171: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Modality (2016-2032)
  - Table 172: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Target Antigen (2016-2032)
  - Table 173: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by Indication (2016-2032)
  - Table 174: Middle East & Africa CAR-T Cell Therapies Market Share Comparison by End-User (2016-2032)
- Juno Therapeutics, Inc.
- Bristol-Myers Squibb Company
- Bluebird Bio, Inc.
- Gilead Sciences, Inc.
- Merck & Co., Inc.
- Pfizer, Inc.
- Sorrento Therapeutics, Inc.
- Merck KGaA Company Profile
- Amgen Inc.
- Eureka Therapeutics Inc.
- Calyxt Inc.
- Autolus Therapeutics
- CARsgen Therapeutics Co.Ltd.
- Poseida Therapeutics, Inc.
- Fortress Biotech, Inc.
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)